(Q34379920)

1 August 2017

1 reference

title

NSAID-related gastrointestinal injury. Evidence-based approach to a preventable complication (English)

1 reference

1 August 2017

M B Fennerty

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

1 August 2017

published in

Postgraduate Medicine

1 reference

1 August 2017

volume

110

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

87-8, 91-4

1 reference

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.09.1020

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.09.1020

NSAIDs, gastrointestinal injury, and cytoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.09.1020

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.09.1020

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.09.1020

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.09.1020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.09.1020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.09.1020

Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.09.1020

21 January 2018

Identifiers

DOI

10.3810/PGM.2001.09.1020

1 reference

1 August 2017

1 reference